Phase II study of linifanib in KRAS mutated metastatic refractory colorectal cancer

被引：0
|
作者：
Chan, E. [1 ]
Ayers, G. D. [2 ]
Goff, L. [1 ]
McClanahan, P. [3 ]
Holloway, M. [3 ]
Ciombor, K. [1 ]
Smith, S. J. [1 ]
Ancell, K. [1 ]
Cardin, D. B. [1 ]
Berlin, J. [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Div Med Oncol, Nashville, TN USA
[2] Vanderbilt Univ, Med Ctr, Ctr Quantitat Sci, Nashville, TN USA
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2369
引用
收藏
页码：S549 / S549
页数：1
相关论文
共 50 条
  • [41] Phase II study of cabozantinib and nivolumab in refractory metastatic microsatellite stable (MSS) colorectal cancer (CRC).
    Leal, Alexis Diane
    Blatchford, Patrick Jud
    Kim, Sunnie S.
    Lentz, Robert William
    Kemme, Douglas Jerome
    Russen, McKenna
    Friedrich, Tyler
    Mathew, Lynn
    Hoyer, Robert John
    Kono, Scott Arthur
    Baiyee Toegel, Emily
    Bagby, Stacey M.
    Dominguez, Adrian
    Davis, S. Lindsey
    Pitts, Todd
    Lieu, Christopher Hanyoung
    Messersmith, Wells A.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 229 - 229
  • [42] SPRY2 and response to FOLFOX/CAPOX in metastatic KRAS mutated colorectal cancer
    Montal, R.
    Merche, M. -V.
    Anta, B.
    Martinez, N.
    Santos, C.
    Sanjuan, X.
    Paules, M. J.
    Perez Martin, F. J.
    Azuara, D.
    Salazar, R.
    Rojas, J. M.
    ANNALS OF ONCOLOGY, 2015, 26
  • [43] A Phase II Trial of Bevacizumab plus Everolimus for Patients with Refractory Metastatic Colorectal Cancer
    Altomare, Ivy
    Bendell, Johanna C.
    Bullock, Karen E.
    Uronis, Hope E.
    Morse, Michael A.
    Hsu, S. David
    Zafar, S. Yousuf
    Blobe, Gerard C.
    Pang, Herbert
    Honeycutt, Wanda
    Sutton, Linda
    Hurwitz, Herbert I.
    ONCOLOGIST, 2011, 16 (08): : 1131 - 1137
  • [44] A PHASE-II TRIAL OF CYCLOSPORINE A IN THE TREATMENT OF REFRACTORY METASTATIC COLORECTAL-CANCER
    MURREN, JR
    GANPULE, S
    SARRIS, A
    DURIVAGE, H
    DAVIS, C
    MAKUCH, R
    HANDSCHUMACHER, RE
    MARSH, JC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (03): : 208 - 210
  • [45] Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503)
    Iwasa, Satoru
    Okita, Natsuko
    Kuchiba, Aya
    Ogawa, Gakuto
    Kawasaki, Mamiko
    Nakamura, Kenichi
    Shoji, Hirokazu
    Honma, Yoshitaka
    Takashima, Atsuo
    Kato, Ken
    Hamaguchi, Tetsuya
    Boku, Narikazu
    Yamada, Yasuhide
    ESMO OPEN, 2020, 5 (04)
  • [46] Association KRAS G13D Tumor Mutated Outcome in Patients with Chemotherapy Refractory Metastatic Colorectal Cancer Treated with Cetuximab
    Tural, Deniz
    Selcukbiricik, Fatih
    Erdamar, Sibel
    Ozkurt, Canan Unlu
    Yanmaz, Teoman
    Mandel, Nil Molinas
    Serdengecti, Suheyla
    HEPATO-GASTROENTEROLOGY, 2013, 60 (125) : 1035 - 1040
  • [47] A PHASE II STUDY ON 3RD-LINE CHEMOTHERAPY COMBINED BEVACIZUMAB WITH S-1 FOR COLORECTAL CANCER WITH MUTATED KRAS
    Miyake, Y.
    Takagane, A.
    Shimada, K.
    Nagata, N.
    Sato, A.
    Ogata, Y.
    Fukunaga, M.
    Otsuka, K.
    Matsubara, Y.
    Yoshida, M.
    ANNALS OF ONCOLOGY, 2013, 24
  • [48] Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
    Fakih, Marwan G.
    Salvatore, Lisa
    Esaki, Taito
    Modest, Dominik P.
    Lopez-Bravo, David P.
    Taieb, Julien
    Karamouzis, Michalis V.
    Ruiz-Garcia, Erika
    Kim, Tae-Won
    Kuboki, Yasutoshi
    Meriggi, Fausto
    Cunningham, David
    Yeh, Kun-Huei
    Chan, Emily
    Chao, Joseph
    Saportas, Yaneth
    Tran, Qui
    Cremolini, Chiara
    Pietrantonio, Filippo
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (23): : 2125 - 2139
  • [49] A phase II study of cetuximab (Erbitux®) plus FOLFIRI for irinotecan and oxaliplatin-refractory metastatic colorectal cancer
    Koo, Dong Hoe
    Lee, Jae-Lyun
    Kim, Tae Won
    Chang, Heung Moon
    Ryu, Min-Hoe
    Lee, Sung Sook
    Kim, Min Kyoung
    Sym, Sun Jin
    Lee, Jung Shin
    Kang, Yoon-Koo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 : S98 - S103
  • [50] A phase II study of nab-paclitaxel in refractory CIMP-high metastatic colorectal cancer.
    Overman, Michael J.
    Kee, Bryan K.
    Fogelman, David R.
    Eng, Cathy
    Sanchez, Eduardo Vilar
    Shroff, Rachna T.
    Dasari, Arvind
    Wolff, Robert A.
    Morris, Jeffrey
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345